|
|
OPEN ACCESS ARTICLE |
| p13 |
miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer |
Shuichi Tatarano, Takeshi Chiyomaru, Kazumori Kawakami, Hideki Enokida, Hirofumi Yoshino, Hideo Hidaka, Takeshi Yamasaki, Kazuya Kawahara, Kenryu Nishiyama, Naohiko Seki, Masayuki Nakagawa
|
|
|
|
| p51 |
High incidence of high-risk HPV in benign and malignant lesions of the larynx |
Anaëlle Duray, Géraldine Descamps, Mohammad Arafa, Christine Decaestecker, Myriam Remmelink, Nicolas Sirtaine, Perle Ernoux-Neufcoeur, Eugène Mutijima, Joan Somja, Christophe E. Depuydt, Philippe Delvenne, Sven Saussez
|
|
|
|
| p73 |
Endosialin is expressed in high grade and advanced sarcomas: Evidence from clinical specimens and preclinical modeling |
Cecile Rouleau, Robert Smale, Yao-Shi Fu, Guodong Hui, Fei Wang, Elizabeth Hutto, Robert Fogle, Craig M. Jones, Roy Krumbholz, Stephanie Roth, Maritza Curiel, Yi Ren, Rebecca G. Bagley, Gina Wallar, Glenn Miller, Steven Schmid, Bruce Horten, Beverly A. Teicher
|
|
|
|
| p203 |
Overexpression of α1,6-fucosyltransferase in hepatoma enhances expression of Golgi phosphoprotein 2 in a fucosylation-independent manner |
Sayuri Kawamoto, Kenta Moriwaki, Tsutomu Nakagawa, Mika Terao, Shinichiro Shinzaki, Naoko Yamane-Ohnuki, Mitsuo Satoh, Anand S. Mehta, Timothy M. Block, Eiji Miyoshi
|
|
|
|
| p217 |
Wogonin triggers apoptosis in human osteosarcoma U-2 OS cells through the endoplasmic reticulum stress, mitochondrial dysfunction and caspase-3-dependent signaling pathways |
Chin-Chung Lin, Chao-Lin Kuo, Mau-Hwa Lee, Kuang-Chi Lai, Jing-Pin Lin, Jai-Sing Yang, Chun-Shu Yu, Chi-Cheng Lu, Jo-Hua Chiang, Fu-Shin Chueh, Jing-Gung Chung
|
|
|
|
OPEN ACCESS ARTICLE |
| p255 |
Bone metastases detection by circulating biomarkers: OPG and RANK-L |
Laura Mercatali, Toni Ibrahim, Emanuele Sacanna, Emanuela Flamini, Emanuela Scarpi, Daniele Calistri, Marianna Ricci, Patrizia Serra, Rossana Ricci, Wainer Zoli, Yibin Kang, Dino Amadori
|
|
|
|
| p271 |
Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancer |
Sandra R. Brave, Rajesh Odedra, Neil H. James, Neil R. Smith, Gayle B. Marshall, Kerry L. Acheson, Dawn Baker, Zoe Howard, Lynsay Jackson, Kirsty Ratcliffe, Anna Wainwright, Susan C. Lovick, D. Mark Hickinson, Robert W. Wilkinson, Simon T. Barry, Georgina Speake, Anderson J. Ryan
|
|
|
|
| p287 |
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad antibody responses in humans, a RAYS-based analysis |
Axel Mischo, Nina Bubel, Jonathan S. Cebon, Panagiotis Samaras, Ulf Petrausch, Frank Stenner-Liewen, Niklaus G. Schaefer, Boris Kubuschok, Christoph Renner, Andreas Wadle
|
|
|
|
|
|